Selection of hepatitis B virus variants with aminoacid substitutions inside the core antigen during interferon-α therapy

Journal of Medical Virology

Volumn 62, Issue 4, 2000, Pages 479-486

  Radecke, Klaus ^a   Protzer, Ulrike ^b   Trippler, Martin ^c   Zum Büschenfelde, Karl Herrmann Meyer ^d   Gerken, Guido ^c  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Aminoacid substitution; HBV; IFN ; Immunodominant epitopes

Indexed keywords

ALPHA INTERFERON; EPITOPE; VIRUS ANTIGEN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; HELPER CELL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOTHERAPY; MALE; VIRUS MUTATION;

ADULT; AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; FEMALE; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNODOMINANT EPITOPES; INTERFERON-ALPHA; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROTEIN PRECURSORS; TREATMENT OUTCOME; VARIATION (GENETICS);

DNA VIRUSES; HEPATITIS B VIRUS;

EID: 0033744741     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9071(200012)62:4<479::AID-JMV13>3.0.CO;2-M     Document Type: Article

References (26)

1. Naturally occurring hepatitis B virus core gene mutations
2. Core variability does not affect response to interferon alpha in HBeAg negative chronic hepatitis B
3. Natural variants of cytotoxic epitopes are T cell receptor antagonists for antiviral cytotoxic T cells
4. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis
5. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection
6. High degree of conservation in the hepatitis B virus core gene during the immune tolerant phase in perinatally acquired chronic hepatitis B infection
7. Emergence of hepatitis B virus S gene mutant in a liver transplant recipient
8. Vaccine-induced escape mutant of hepatitis B virus
9. Viral genetic variation: Hepatitis B virus as a clinical example
10. Hepatitis B e antigen negative chronic active hepatitis: Hepatitis B virus core mutations occur predominantly in known antigenic determinants
11. Hepatitis B virus core protein mutations are concentrated in B cell epitopes in progressive disease and in T helper cell epitopes during clinical remisson
12. Hepatitis B virus immunopathogenesis
13. Identification of a major hepatitis B core antigen (HBcAg) determinant by using synthetic peptides and monoclonal antibodies
14. Variations in codons 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection
15. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis
16. Hepatitis B virus preCore/Core variation and interferon therapy
17. Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen
18. Interferon therapy in viral hepatitis
19. Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II restricted T cell epitopes
20. Polyclonality and multispecificity of the CTL response to a single viral epitope
21. Novel pre-C/C gene mutants of hepatitis B virus in chronic active hepatitis: Naturally occurring escape mutants
22. HLA-A31-and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis
23. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen
24. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation
25. Mechanisms of immune escape in viral hepatitis
26. Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus